Comments
Will the Government push back on its Oxytocin ban on private companies that prevents them from making and marketing the product? Or will it be the Delhi High Court that rules on the issue?
The coming week will see multinational drugmaker Mylan’s writ petition come up at the Delhi HC. The court is likely to hear the plea on August 20. The petition challenges the Government’s ban on private makers of Oxytocin. Also seeking to be heard with them is civil society group All India Drug Action Network that has filed a Public Interest Litigation at the Delhi HC.
Oxytocin treats excessive bleeding in women during childbirth. But its misuse in cattle and poultry to increase milk secretion and production, in addition to concerns of misuse in young girls, triggered the Government’s crackdown. However, doctors caution that restriction on private supplies of Oxytocin could create a shortage, despite one Government company being appointed to make the drug. The coming fortnight could see much legal action in the lead-up to September 1, when the ban is to come into effect.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.